ABCL
Price
$3.76
Change
+$0.13 (+3.58%)
Updated
Apr 26, 6:59 PM EST
11 days until earnings call
QSI
Price
$1.65
Change
+$0.04 (+2.48%)
Updated
Apr 26, 6:59 PM EST
13 days until earnings call
Ad is loading...

Compare trend and price ABCL vs QSI

Header iconABCL vs QSI Comparison
Open Charts ABCL vs QSIBanner chart's image
AbCellera Biologics
Price$3.76
Change+$0.13 (+3.58%)
Volume$853.92K
CapitalizationN/A
Quantum-Si
Price$1.65
Change+$0.04 (+2.48%)
Volume$199.11K
CapitalizationN/A
View a ticker or compare two or three
ABCL vs QSI Comparison Chart

Loading...

ABCLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
QSIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ABCL vs. QSI commentary
Apr 27, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and QSI is a Hold.

COMPARISON
Comparison
Apr 27, 2024
Stock price -- (ABCL: $3.63 vs. QSI: $1.61)
Brand notoriety: ABCL and QSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 133% vs. QSI: 53%
Market capitalization -- ABCL: $1.06B vs. QSI: $228.25M
ABCL [@Biotechnology] is valued at $1.06B. QSI’s [@Biotechnology] market capitalization is $228.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $562.44B to $0. The average market capitalization across the [@Biotechnology] industry is $2.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileQSI’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • QSI’s FA Score: 0 green, 5 red.
According to our system of comparison, QSI is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while QSI’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 4 bearish.
  • QSI’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than QSI.

Price Growth

ABCL (@Biotechnology) experienced а -7.16% price change this week, while QSI (@Biotechnology) price change was +6.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.51%. For the same industry, the average monthly price growth was -3.37%, and the average quarterly price growth was +1265.61%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 07, 2024.

QSI is expected to report earnings on Aug 05, 2024.

Industries' Descriptions

@Biotechnology (+7.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ABCL with price predictions.
OPEN
A.I.dvisor published
a Summary for QSI with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ABCL($1.06B) has a higher market cap than QSI($228M). QSI YTD gains are higher at: -19.900 vs. ABCL (-36.427).
ABCLQSIABCL / QSI
Capitalization1.06B228M466%
EBITDAN/AN/A-
Gain YTD-36.427-19.900183%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
ABCLQSI
RSI
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend about 1 month ago
74%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
ABCLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
QSIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSAQX19.190.08
+0.42%
Morgan Stanley Inst Asia Opp I
AMAGX75.660.09
+0.12%
Amana Growth Investor
VRKSX9.72N/A
N/A
Virtus KAR Small-Mid Cap Growth R6
ABWIX14.75-0.04
-0.27%
AB All Market Total Return I
TIEUX13.75-0.04
-0.29%
Morgan Stanley Pathway Intl Eq

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with DNA. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then DNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-6.92%
DNA - ABCL
56%
Loosely correlated
-8.05%
NTLA - ABCL
56%
Loosely correlated
-5.43%
VCYT - ABCL
56%
Loosely correlated
-2.11%
RXRX - ABCL
54%
Loosely correlated
-1.26%
AXON - ABCL
51%
Loosely correlated
+1.27%
More

QSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, QSI has been loosely correlated with AXON. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if QSI jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QSI
1D Price
Change %
QSI100%
-3.59%
AXON - QSI
49%
Loosely correlated
+1.27%
VCYT - QSI
47%
Loosely correlated
-2.11%
DNA - QSI
45%
Loosely correlated
-8.05%
ABCL - QSI
44%
Loosely correlated
-6.92%
MNMD - QSI
44%
Loosely correlated
+0.71%
More